| 價(jià)格 | ¥112 | ¥248 | ¥397 |
| 包裝 | 1mg | 5mg | 10mg |
| 最小起訂量 | 1mg |
| 發(fā)貨地 | 上海 |
| 更新日期 | 2026-06-29 |
| 中文名稱:化合物 GSK2200150A | 英文名稱:GSK2200150A |
| CAS:1443138-53-1 | 品牌: TargetMol |
| 產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 純度規(guī)格: 99.24% | 產(chǎn)品類別: 抑制劑 |
| 貨號(hào): T4531 |
| 名稱 | GSK2200150A |
| 描述 | GSK2200150A is an anti-tuberculosis (TB) agent identified by high-throughput screening (HTS) campaign. |
| 細(xì)胞實(shí)驗(yàn) | GSK2200150A is tested for activity at either single concentration (100 μM) or serially diluted in 10 μL of purified H2O in triplicate in 96 well microtiter plates. M. tuberculosis H37Rv is grown in complete Middlebrook 7H9 media containing albumin, dextrose and catalase (ADC), 20% Tween 80 and 50% glycerol. A bacterial suspension (90 μL) at OD600 nm of 0.001 is added to the wells and incubated for 7 days. Resazurin (10 μL; 0.05%(w/v)) is then added, incubated for 24 h at 37°C, and fluorescence measured at 590 nm using a FLUOstar Omega microplate reader. After subtraction of background fluorescence from all wells, the percentage mycobacterial survival is determined by comparing the fluorescence of wells containing compounds compared to control wells not treated with compound[1]. |
| 體外活性 | GSK2200150A 是一種針對(duì)結(jié)核分枝桿菌(Mycobacterium tuberculosis)的新型抗菌藥物。含有螺旋環(huán)核心的 GSK2200150A 對(duì)致病性的 M.tuberculosis 株(H37Rv)顯示出顯著的活性,最小抑菌濃度(MIC)為 0.38 μM [1]。 |
| 存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | DMSO : 45 mg/mL (125.88 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (5.59 mM), Sonication is recommended. |
| 關(guān)鍵字 | Inhibitor | inhibit | GSK-2200150A | GSK2200150A | Bacterial |
| 相關(guān)產(chǎn)品 | Adipic dihydrazide | Levulinic acid | Doxycycline | Neomycin sulfate | Terbinafine hydrochloride | BES | Sodium bicarbonate | Hyaluronic acid sodium (MW 20 kDa) | Sodium diacetate | Sulfamethoxazole sodium | Kanamycin sulfate | D(+)-Raffinose pentahydrate |
| 相關(guān)庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 | 抗菌活性庫 | 抗感染化合物庫 | NO PAINS 化合物庫 |
| 成立日期 | 2013-04-18 (14年) | 注冊(cè)資本 | 566.265100萬人民幣 |
| 員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
| 主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
|---|---|---|---|---|
| 詢價(jià) |
河北冀肽生物科技有限公司
|
2026-07-29 | ||
| 詢價(jià) |
VIP1年
|
河南伊諾凱新材料有限公司
|
2026-06-11 | |
| 詢價(jià) |
VIP8年
|
廣州市桐暉藥業(yè)有限公司
|
2026-06-02 |